225 related articles for article (PubMed ID: 33099377)
21. Surgical methods for full-thickness skin grafts to induce alopecia areata in C3H/HeJ mice.
Silva KA; Sundberg JP
Comp Med; 2013 Oct; 63(5):392-7. PubMed ID: 24210015
[TBL] [Abstract][Full Text] [Related]
22. Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata.
McElwee KJ; Silva K; Beamer WG; King LE; Sundberg JP
Exp Dermatol; 2001 Dec; 10(6):420-9. PubMed ID: 11737261
[TBL] [Abstract][Full Text] [Related]
23. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.
McElwee KJ; Freyschmidt-Paul P; Hoffmann R; Kissling S; Hummel S; Vitacolonna M; Zöller M
J Invest Dermatol; 2005 May; 124(5):947-57. PubMed ID: 15854035
[TBL] [Abstract][Full Text] [Related]
24. Similarities of dermoscopic findings in alopecia areata between human and C3H/HeJ mouse.
Suzuki T; Tokura Y; Ito T
J Dermatol Sci; 2016 Aug; 83(2):154-7. PubMed ID: 27157926
[No Abstract] [Full Text] [Related]
25. Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.
Shin JM; Choi DK; Sohn KC; Koh JW; Lee YH; Seo YJ; Kim CD; Lee JH; Lee Y
Sci Rep; 2018 Aug; 8(1):12518. PubMed ID: 30131581
[TBL] [Abstract][Full Text] [Related]
26. Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice.
Wang E; Chong K; Yu M; Akhoundsadegh N; Granville DJ; Shapiro J; McElwee KJ
PLoS One; 2013; 8(4):e62935. PubMed ID: 23658656
[TBL] [Abstract][Full Text] [Related]
27. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.
Nakamura M; Jo J; Tabata Y; Ishikawa O
Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811
[TBL] [Abstract][Full Text] [Related]
28. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model.
Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T
J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266
[TBL] [Abstract][Full Text] [Related]
29. NLRP3 inflammasome activation contributes to development of alopecia areata in C3H/HeJ mice.
Hashimoto K; Yamada Y; Sekiguchi K; Mori S; Matsumoto T
Exp Dermatol; 2022 Feb; 31(2):133-142. PubMed ID: 34270818
[TBL] [Abstract][Full Text] [Related]
30. [Alopecia areata in animal models--new insights into pathogenesis and treatment of a T cell-mediated autoimmune disorder].
Freyschmidt-Paul P; Happle R; Hoffman R
J Dtsch Dermatol Ges; 2004 Apr; 2(4):260-73. PubMed ID: 16285322
[TBL] [Abstract][Full Text] [Related]
31. C3H/HeJ mouse model for alopecia areata.
Sundberg JP; Boggess D; Montagutelli X; Hogan ME; King LE
J Invest Dermatol; 1995 May; 104(5 Suppl):16S-17S. PubMed ID: 7738375
[No Abstract] [Full Text] [Related]
32. Endogenous retinoids in the pathogenesis of alopecia areata.
Duncan FJ; Silva KA; Johnson CJ; King BL; Szatkiewicz JP; Kamdar SP; Ong DE; Napoli JL; Wang J; King LE; Whiting DA; McElwee KJ; Sundberg JP; Everts HB
J Invest Dermatol; 2013 Feb; 133(2):334-43. PubMed ID: 23014334
[TBL] [Abstract][Full Text] [Related]
33. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model.
Zhang X; Yu M; Yu W; Weinberg J; Shapiro J; McElwee KJ
J Invest Dermatol; 2009 Jun; 129(6):1527-38. PubMed ID: 19020552
[TBL] [Abstract][Full Text] [Related]
34. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
35. Alopecia areata: updates from the mouse perspective.
Sundberg JP; Berndt A; Silva KA; Kennedy VE; Sundberg BA; Everts HB; Rice RH; King LE
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S23-4. PubMed ID: 24326543
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
37. 2-deoxy D-glucose treatment does not elicit a hair growth response in alopecia areata.
Sundberg JP; Silva KA; Kennedy VE; Wilson JJ; Gott NE; Sundberg BA; Roopenian DC
Exp Dermatol; 2019 Sep; 28(9):1091-1093. PubMed ID: 31323149
[TBL] [Abstract][Full Text] [Related]
38. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic?
Kaufman G; d'Ovidio R; Kaldawy A; Assy B; Ullmann Y; Etzioni A; Paus R; Gilhar A
Exp Dermatol; 2010 Aug; 19(8):e347-9. PubMed ID: 20653774
[TBL] [Abstract][Full Text] [Related]
39. Alopecia areata.
King LE; McElwee KJ; Sundberg JP
Curr Dir Autoimmun; 2008; 10():280-312. PubMed ID: 18460892
[TBL] [Abstract][Full Text] [Related]
40. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
